In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Brecklinghaus, T
- Albrecht, W
- Duda, J
- Kappenberg, F
- Gruendler, Lisa
- Edlund, K
- Marchan, R
- Ghallab, A
- Cadenas, C
- Rieck, A
- Vartak, N
- Gardner, I
- Halilbasic, E
- Trauner, M
- Ullrich, A
- Zeigerer, A
- Turgunbayer, ÖD
- Damm, G
- Seehofer, D
- Rahnenfuhrer, J
- Hengstler, JG
Grupos
Abstract
The accumulation of lipid droplets in hepatocytes is a key feature of drug-induced liver injury (DILI) and can be induced by a subset of hepatotoxic compounds. In the present study, we optimized and evaluated an in vitro technique based on the fluorescent dye Nile Red, further named Nile Red assay to quantify lipid droplets induced by the exposure to chemicals. The Nile Red assay and a cytotoxicity test (CTB assay) were then performed on cells exposed concentration-dependently to 60 different compounds. Of these, 31 were known to induce hepatotox-icity in humans, and 13 were reported to also cause steatosis. In order to compare in vivo relevant blood con-centrations, pharmacokinetic models were established for all compounds to simulate the maximal blood concentrations (Cmax) at therapeutic doses. The results showed that several hepatotoxic compounds induced an increase in lipid droplets at sub-cytotoxic concentrations. To compare how well (1) the cytotoxicity test alone, (2) the Nile Red assay alone, and (3) the combination of the cytotoxicity test and the Nile Red assay (based on the lower EC10 of both assays) allow the differentiation between hepatotoxic and non-hepatotoxic compounds, a previously established performance metric, the Toxicity Separation Index (TSI) was calculated. In addition, the Toxicity Estimation Index (TEI) was calculated to determine how well blood concentrations that cause an increased DILI risk can be estimated for hepatotoxic compounds. Our findings indicate that the combination of both assays improved the TSI and TEI compared to each assay alone. In conclusion, the study demonstrates that inclusion of the Nile Red assay into in vitro test batteries may improve the prediction of DILI compounds.
Copyright © 2022. Published by Elsevier B.V.
Datos de la publicación
- ISSN/ISSNe:
- 0378-4274, 1879-3169
- Tipo:
- Article
- Páginas:
- 33-46
- PubMed:
- 35963427
- Factor de Impacto:
- 0,804 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
TOXICOLOGY LETTERS ELSEVIER IRELAND LTD
Citas Recibidas en Web of Science: 9
Documentos
- No hay documentos
Filiaciones
Keywords
- Steatosis; DILI; Alternative methods; NAFLD; Lipid droplets
Cita
Brecklinghaus T,Albrecht W,Duda J,Kappenberg F,Gruendler L,Edlund K,Marchan R,Ghallab A,Cadenas C,Rieck A,Vartak N,TOLOSA L,CASTELL J,Gardner I,Halilbasic E,Trauner M,Ullrich A,Zeigerer A,Turgunbayer ÖD,Damm G,Seehofer D,Rahnenfuhrer J,Hengstler JG. In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay. Toxicol. Lett. 2022. 368. p. 33-46. IF:3,500. (2).
Portal de investigación